Core Viewpoint - The company, JieTe Bio (688026.SH), is focused on providing comprehensive solutions for biological experiments and biopharmaceuticals, with a significant emphasis on biological filtration as an essential component of these processes [1] Group 1: Company Developments - JieTe Bio has previously relied on overseas suppliers for its filtration-related products, but since 2021, the company's actual controller has established JieKe Membrane to develop necessary filtration products [1] - JieKe Membrane has completed foundational research on filtration product technology and has developed several basic products [1] - The company plans to acquire 70% of JieKe Membrane from investors for a total of RMB 7.9199 million, which will make JieKe Membrane a subsidiary and included in the company's consolidated financial statements [1]